Benzinga | May 3, 2021 04:49PM EDT

Lantern Pharma Q1 EPS $(0.24) Beats $(0.27) Estimate

Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.27) by 11.11 percent.